# Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart Failure

> **NCT00766857** · PHASE4 · COMPLETED · sponsor: **Amsterdam UMC, location VUmc** · enrollment: 27 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus
- Congestive Heart Failure

## Interventions

- **DRUG:** exenatide
- **DRUG:** Insulin glargine

## Key facts

- **NCT ID:** NCT00766857
- **Lead sponsor:** Amsterdam UMC, location VUmc
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2015-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00766857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00766857, "Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart Failure". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00766857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*